Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of c-reactive protein
- PMID: 15663536
- DOI: 10.1111/j.1526-0968.2004.00173.x
Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of c-reactive protein
Abstract
A 68-year-old-male who was diagnosed as having rheumatoid arthritis (RA) 7 years previously was admitted the Chiba Social Insurance Hospital due to general fatigue, spiking fever, and appetite loss. Blood tests showed extremely high levels of C-reactive protein (CRP, 318.5 mg/dL), and hypergammapathy (IgG 3228 mg/dL, IgA 905 mg/dL, IgM 2537 mg/dL) and high titers of rheumatoid factor (RAPA 40960X). He was diagnosed as having RA with vasculitis, according to interstitial pneumonitis, cutaneous nodules and polyneuropathy. Prednisolone (30 mg/day) was prescribed, however, myeloperoxidase-antineutrophil cytoplasmic antibody proved to be positive (86EU) and cyclophosphamide (50 mg/day) was added one week later. Additionally, IgM K-chain M-protein was revealed and the differentiation between auto-immune and hematologic diseases was required for further drug prescriptions. Therefore, double filtration plasmapheresis (DFPP) was initiated weekly. Hematologic diseases were negated and the hypergammapathy was improved. C-reactive protein and MPO-ANCA decreased to the normal level after three sessions (IgG 1064 mg/dL, IgA 331 mg/dL, IgM 94 mg/dL, CRP 0.04 mg/dL) and the patients symptoms improved. Prednisolone was tapered and he was discharged. It was suggested that the case presented here was quite rare, having an extremely high level of CRP which was successfully managed by DFPP.
Similar articles
-
More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.Ther Apher Dial. 2013 Feb;17(1):93-8. doi: 10.1111/j.1744-9987.2012.01107.x. Epub 2012 Nov 20. Ther Apher Dial. 2013. PMID: 23379500
-
[Observation on effect of double filtration plasmapheresis on patients with active rheumatoid arthritis in active stage].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Sep;17(9):568-9. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005. PMID: 16146609 Chinese.
-
A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.J Clin Rheumatol. 2007 Aug;13(4):193-8. doi: 10.1097/RHU.0b013e318124a483. J Clin Rheumatol. 2007. PMID: 17762452 Clinical Trial.
-
[Two cases of rheumatoid arthritis developed after polymyositis].Ryumachi. 2003 Jun;43(3):583-90. Ryumachi. 2003. PMID: 12910969 Review. Japanese.
-
[Plasmapheresis for patients with RA].Nihon Rinsho. 1992 Mar;50(3):543-6. Nihon Rinsho. 1992. PMID: 1588745 Review. Japanese.
Cited by
-
Changes in Water Properties in Human Tissue after Double Filtration Plasmapheresis-A Case Study.Molecules. 2022 Jun 20;27(12):3947. doi: 10.3390/molecules27123947. Molecules. 2022. PMID: 35745071 Free PMC article.
-
Efficacy and safety of dual filtration plasmapheresis combined with biological agents in active refractory rheumatod arthritis: A retrospective cohort study.Medicine (Baltimore). 2020 Jul 10;99(28):e20966. doi: 10.1097/MD.0000000000020966. Medicine (Baltimore). 2020. PMID: 32664100 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous